Zydus Cancer Hospital, Ahmedabad marks 200+ Stereotactic Radiotherapy (SRT)/SRS for Brain Tumours

About this update from Zydus Lifesciences Limited

Non-Invasive High Precision Therapy with Linear Accelerator (LINAC) AHMEDABAD, India, May 19, 2026 /PRNewswire/ -- Zydus Cancer Hospital, Ahmedabad, successfully performs over 200 Non-Invasive Radiotherapy procedures under the expertise of Dr. Sandeep Jain, Radiation Oncologist and team, marking a major milestone in advanced neuroscience care with excellent outcomes. Stereotactic Radiotherapy (SRT) or Radiosurgery (SRS) involves no incision and can be an outpatient procedure. It offers exceptional precision in treating complex brain tumours, metastatic lesions, and multiple tumours without the need for general anaesthesia or prolonged hospitalization. This advanced technology is particularly effective for conditions such as arteriovenous malformations (AVMs), meningiomas, vestibular schwannomas, glomus tumours, pituitary adenomas, skull base tumours and other hard-to-reach lesions. Using advanced imaging guidance and sub-millimetre precision, this technology (Versa HD LINAC) can treat patients who would otherwise require Gamma Knife procedures. In addition, it is also capable of treating large and irregularly shaped tumours by using highly focused X-rays with high precision directed to the target while protecting surrounding healthy tissue. In addition, its cone beam with CT scan with robotic couch can verify tumour position accurately using 3D imaging, which was not available in machines of previous generations. Treatment is completed in one to five sessions, helping patients recover faster with minimal disruption of their work. It is particularly useful for treating tumours in the brain's eloquent (critical) locations that include the motor area, brainstem and the optic pathway. In these brain locations, it is difficult to operate, and sometimes even taking a biopsy can be challenging. It also offers local disease control without the neurocognitive side effects associated with whole-brain radiotherapy. "Now we can target larger, irregular and difficult-to-treat tumours with this technology, which was not possible before", said Dr. Sandeep Jain, who has treated a large spectrum of patients, right from the youngest being only 6 years old to even the frailest patients. Up to 4 tumours can be targeted with stereotactic r...

View stock analysis, news, and events for Zydus Lifesciences Limited